🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Drugs used in chemotherapy, such as doxorubicin hydrochloride, b...
Status
Terminated
Location
Stanford Cancer Center
Start Date
2013-05-24
Trial ID
NCT01390584
The purpose of this study is to evaluate the safety and efficacy of pembrol...
Status
Completed
Location
St Joseph Heritage Healthcare-Oncology ( Site 0004)
Start Date
2021-10-07
Trial ID
NCT05008224
RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells,...
Status
Completed
Location
Kaiser Franz Josef Hospital
Start Date
1996-08
Trial ID
NCT00002840
Treatments Being Tested
This is a randomized, open-label, multi-center, phase 2 study of RCHOP with...
Status
Completed
Location
Tower Cancer Research Foundation
Start Date
2009-10
Trial ID
NCT00931918
Treatments Being Tested
Previously untreated CD20 positive diffuse large B-cell lymphoma (DLBCL) re...
Status
Completed
Location
Southampton University Hospitals NHS Tust
Start Date
2017-06-02
Trial ID
NCT03571308
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cel...
Status
Completed
Location
Hospital Italiano de Buenos Aires
Start Date
1999-10
Trial ID
NCT00004218
This study will be conducted to evaluate the effect of vitamin B6 and vitam...
Status
Completed
Location
Bangabandhu Sheikh Mujib Medical University
Start Date
2018-03-29
Trial ID
NCT03593304
Treatments Being Tested
RATIONALE: Monoclonal antibodies, such as rituximab and yttrium Y 90 ibritu...
Status
Completed
Location
Comprehensive Cancer Center at University of Alabama at Birmingham
Start Date
2003-11
Trial ID
NCT00070447
This randomized phase III trial studies how well imatinib mesylate works in...
Status
Active Not Recruiting
Location
Children's Hospital of Alabama
Start Date
2017-08-08
Trial ID
NCT03007147
Treatments Being Tested
This phase II trial studies how well a dose adjusted regimen consisting of ...
Status
Completed
Location
M D Anderson Cancer Center
Start Date
2015-01-14
Trial ID
NCT02199184